The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says
In Brief: Deisseroth Leaves M.D. Anderson To Head Yale’s Oncology, Gene Therapy Programs
Intramural Funding To Decrease, R01s Increase, Klausner Says
Harlow, Abeloff To Chair BSC Subcommittees; Livingston To Head Extramural Advisors
New Structure Of Divisions Outlined
“Flat” Administrative Structure To Include Resource Teams
Next Bypass Budget: Slim, Trim, Modest
Trending Stories
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Peter F. Garrett to people with cancer: Your story has power
- What NHS-Galleri taught us—and what it didn’t
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”









